Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-25-000003

Chief Executive Officer gave up 11,581 shares (to pay taxes)

  • Chief Executive Officer acquired 24,484 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shea Jacqueline Elizabeth · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Exercise or conversion : show line 1 in the form +5,852 39,499 D
2025-02-26 Shares withheld for taxes : show line 2 in the form −2,493 $1.98 $4,936 37,006 D
2025-02-26 Exercise or conversion : show line 3 in the form +18,632 55,638 D
2025-02-26 Shares withheld for taxes : show line 4 in the form −9,088 $1.98 $17,994 46,550 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-02-26 Exercise or conversion : show line 5 in the form Restricted Stock Unit −5,852 0 D
2025-02-26 Exercise or conversion : show line 6 in the form Restricted Stock Unit −18,632 37,263 D
2025-02-27 Grant or award : show line 7 in the form Common Stock Option +105,649 105,649 D
2025-02-27 Grant or award : show line 8 in the form Restricted Stock Unit +85,201 85,201 D
Loading xslF345X05/wk-form4_1740783933.xml…